These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2956315)

  • 1. Oral immunotherapy: a way forward?
    Platts-Mills TA
    J Allergy Clin Immunol; 1987 Aug; 80(2):129-32. PubMed ID: 2956315
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergen immunotherapy.
    Ewan PW
    Curr Opin Immunol; 1989 Apr; 1(4):672-8. PubMed ID: 2679719
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen.
    Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific immunotherapy by different allergen applications: subcutaneous, sublingual, oral or rectal administration and lymph node injection.
    Kleine-Tebbe J
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():87-95; discussion 95. PubMed ID: 20799448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Specific immunotherapy: indications and contraindications].
    Reinhardt MC
    Rev Med Suisse Romande; 1994 Mar; 114(3):233-43. PubMed ID: 8171233
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral allergen immunotherapy by targeting Peyer's patches.
    Roth-Walter F
    Allergy; 2019 Aug; 74(8):1594-1597. PubMed ID: 31006121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of allergy by oral hyposensitization].
    Iorde V; Latsinik G
    Klin Med (Mosk); 1996; 74(4):27-9. PubMed ID: 8999146
    [No Abstract]   [Full Text] [Related]  

  • 8. How does sublingual immunotherapy work?
    Frew AJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy (desensitization) in allergic disease.
    Norman PS
    Annu Rev Med; 1975; 26():337-44. PubMed ID: 1096771
    [No Abstract]   [Full Text] [Related]  

  • 10. New routes and formulations for allergen-specific immunotherapy.
    Wheeler AW; Drachenberg KJ
    Allergy; 1997 Jun; 52(6):602-12. PubMed ID: 9226053
    [No Abstract]   [Full Text] [Related]  

  • 11. Poison oak hyposensitization. Evaluation of purified urushiol.
    Epstein WL; Baer H; Dawson CR; Khurana RG
    Arch Dermatol; 1974 Mar; 109(3):356-60. PubMed ID: 4273614
    [No Abstract]   [Full Text] [Related]  

  • 12. Advantages and disadvantages of accelerated immunotherapy schedules.
    Cox L
    J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergen-specific immunotherapy: current concepts and future directions.
    Bieber T; Simon HU
    Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373
    [No Abstract]   [Full Text] [Related]  

  • 14. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
    Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
    Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
    [No Abstract]   [Full Text] [Related]  

  • 15. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 16. What is the factor that improves adherence to allergen-specific immunotherapy? A secretary!
    Lombardi C
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):530-1. PubMed ID: 25863450
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological mechanisms of allergen-specific immunotherapy.
    Larché M; Akdis CA; Valenta R
    Nat Rev Immunol; 2006 Oct; 6(10):761-71. PubMed ID: 16998509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells in allergen-specific immunotherapy.
    Novak N
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():91-2. PubMed ID: 19221629
    [No Abstract]   [Full Text] [Related]  

  • 19. Rush injection therapy for asthma and allergic rhinitis.
    Greenberger PA
    Ann Allergy; 1994 Nov; 73(5):378-80. PubMed ID: 7978528
    [No Abstract]   [Full Text] [Related]  

  • 20. The current status of allergen immunotherapy (hyposensitisation). Report of a WHO/IUIS working group.
    Allergy; 1989 Aug; 44(6):369-79. PubMed ID: 2679219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.